Mirae Asset Global Investments’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$150K Buy
3,062
+423
+16% +$20.7K ﹤0.01% 1084
2025
Q1
$143K Buy
2,639
+69
+3% +$3.74K ﹤0.01% 1087
2024
Q4
$116K Sell
2,570
-212
-8% -$9.59K ﹤0.01% 1124
2024
Q3
$104K Buy
2,782
+492
+21% +$18.5K ﹤0.01% 1180
2024
Q2
$79.4K Sell
2,290
-39,401
-95% -$1.37M ﹤0.01% 1172
2024
Q1
$1.7M Sell
41,691
-4,078
-9% -$166K ﹤0.01% 1280
2023
Q4
$1.26M Buy
45,769
+6,335
+16% +$175K ﹤0.01% 1495
2023
Q3
$884K Buy
39,434
+122
+0.3% +$2.73K ﹤0.01% 1577
2023
Q2
$1.6M Buy
39,312
+1,139
+3% +$46.4K ﹤0.01% 1323
2023
Q1
$1.85M Buy
38,173
+5,829
+18% +$282K ﹤0.01% 1247
2022
Q4
$1.23M Buy
32,344
+965
+3% +$36.8K ﹤0.01% 1376
2022
Q3
$1.58M Buy
31,379
+8,975
+40% +$451K ﹤0.01% 1253
2022
Q2
$898K Buy
+22,404
New +$898K ﹤0.01% 1452
2021
Q2
Sell
-129,565
Closed -$6.14M 1729
2021
Q1
$6.14M Buy
129,565
+59,345
+85% +$2.81M 0.02% 692
2020
Q4
$4.29M Buy
70,220
+29,355
+72% +$1.79M 0.02% 687
2020
Q3
$1.91M Buy
40,865
+12,888
+46% +$603K 0.01% 792
2020
Q2
$1.42M Buy
27,977
+5,540
+25% +$281K 0.01% 797
2020
Q1
$1M Buy
22,437
+2,445
+12% +$109K 0.01% 822
2019
Q4
$960K Buy
19,992
+1,350
+7% +$64.8K 0.01% 975
2019
Q3
$630K Buy
18,642
+13,255
+246% +$448K ﹤0.01% 1082
2019
Q2
$242K Buy
+5,387
New +$242K ﹤0.01% 1328
2019
Q1
Sell
-37,036
Closed -$1.27M 1344
2018
Q4
$1.27M Buy
37,036
+5,036
+16% +$173K 0.01% 716
2018
Q3
$1.5M Buy
+32,000
New +$1.5M 0.01% 726
2015
Q4
Sell
-57,358
Closed -$1.53M 475
2015
Q3
$1.53M Buy
57,358
+19,670
+52% +$525K 0.06% 240
2015
Q2
$1.81M Buy
+37,688
New +$1.81M 0.06% 222